Alterations in serum bilirubin during enasidenib treatment in patients with or without UGT1A1 mutations Meeting Abstract


Authors: Fathi, A. T.; Dinardo, C. D.; Kline, I.; Tu, N.; Attar, E. C.; Stein, E. M.; de Botton, S.
Abstract Title: Alterations in serum bilirubin during enasidenib treatment in patients with or without UGT1A1 mutations
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Language: English
ACCESSION: WOS:000442916006293
DOI: 10.1200/JCO.2018.36.15_suppl.e19003
PROVIDER: wos
Notes: Meeting Abstract: e19003 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    342 Stein